{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidbro3lgsgb3rh3vm3m3424r4w65k2ou2cumgb5wng77m435zxhk4",
    "uri": "at://did:plc:5sge6nlknzhf4o5bdlhbzlwt/app.bsky.feed.post/3mlec5cwb3be2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig4m62mknsp6etowg77i3tf2jt475jgclivld4qdmhvnlagdtkddi"
    },
    "mimeType": "image/jpeg",
    "size": 195223
  },
  "path": "/story/are-glp1s-longevity-drugs",
  "publishedAt": "2026-05-08T15:13:42.000Z",
  "site": "https://www.gq.com",
  "tags": [
    "Wellness"
  ],
  "textContent": "Medications like Ozempic and Zepbound are reducing the risk of death for people with certain conditions. Can they do the same for everyone else?",
  "title": "Are GLP-1s Longevity Drugs?"
}